PETALING JAYA: Pentamaster Corp Bhd
’s 2024 earnings growth will be underpinned by the automotive and medical segments.
Its first quarter 2024 (1Q24) order-book replenishment is largely driven by robust automotive orders, particularly from China while its automotive product and medical customer diversification plan remains on track.
Phillip Capital expects the medical segment to make up about 30% to 40% of the group revenue in 2024 (2023: 21%) while targeting a healthy group-level gross profit margin of 30% to 33%.
...